IMD and Susceptibility to COVID19

JIMD Podcasts
10/07/2020 10 min
IMD and Susceptibility to COVID19

Listen "IMD and Susceptibility to COVID19"

Descargar episodio Ver en sitio original

Episode Synopsis

Professor Peter Clayton of the Institute for Child Health speaks to the JIMD Podcast about recent findings suggesting that an inborn error in a proline transporter could increase susceptibility to severe CoVID19 disease.

Is susceptibility to severe COVID ‐19 disease an inborn error of metabolism?
Peter Clayton

https://doi.org/10.1002/jimd.12280

More episodes of the podcast JIMD Podcasts

Shortcast: Liver Directed Rx don’t change biochemistry nor Leukodystrophy in Biallelic HMBS Variants 30/12/2025
Sixty Years of Metabolic Medicine: A Conversation with Jean-Marie Saudubray and Manuel Schiff 23/12/2025
Continuous Glucose Monitoring in hepatic GSDs 16/12/2025
Metabolic mysteries: Developmental delay, hepatoblastoma and a VUS 09/12/2025
Biomarkers in Niemann-Pick type C: Preparing for Clinical Trials 02/12/2025
Shortcast: Exploratory Study on the Challenges of Newborn Screening for Lysosomal Storage Disorders 25/11/2025
Chenodeoxycholic acid in Cerebrotendinous Xanthomatosis 18/11/2025
IMD Research Round-Up: Mitochondrial disease 11/11/2025
First in human gene editing: a new era for IMD therapies 04/11/2025
Metabolic mysteries: A 61-year-old with rhabdomyolysis and lifelong episodic fatigue 28/10/2025
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA